Clear Outcomes Results. Stock responds negatively

[anonymous]

Great reply. We see you all over other company boards posting Karen responses or posting Dumb Ass Rep. Get some new material junior. What a loser.

 

[anonymous]

Great reply. We see you all over other company boards posting Karen responses or posting Dumb Ass Rep. Get some new material junior. What a loser.

Dumb. Ass. Karen.

 

[anonymous]

Don’t be a girl!! Man up!

 

[anonymous]

Great reply. We see you all over other company boards posting Karen responses or posting Dumb Ass Rep. Get some new material junior. What a loser.[


Here’s new Material!!!

Countdown in less than 1 hour!!!!

 

[anonymous]

It's Clear that Esperion missed their financial targets for tge quarter. Why would your stock drop 5% if everyone is so giddy about the Notso Clear Data??Just let that resonate for a bit.

I hear Crickets

 

[anonymous]

Great reply. We see you all over other company boards posting Karen responses or posting Dumb Ass Rep. Get some new material junior. What a loser.[


Here’s new Material!!!

Countdown in less than 1 hour!!!!

What's the matter, sugars? Imagine the lonely idiots that have stalked a board because they were not hired three years ago recommending new material. Okay, dumbasses. I'm going to keep picking on all of you because it bothersome all to you're fragile and pathetic egos. Talk to you soon, business plan morons!!!

 

[anonymous]

Angry dude. Look at trial results dumbass ! No reduction in death over placebo!!. 20% LDL reduction!! Statins get 40-50%. This wasn't good despite Steve massaging the data. 14k patients and this was the best they could do. Side effects higher than normal with gout leading the way. So maybe the Dumb ass Karen guy and Oh Karen guy can now go do a circle jerk together. Losers!

 

[anonymous]

Angry dude. Look at trial results dumbass ! No reduction in death over placebo!!. 20% LDL reduction!! Statins get 40-50%. This wasn't good despite Steve massaging the data. 14k patients and this was the best they could do. Side effects higher than normal with gout leading the way. So maybe the Dumb ass Karen guy and Oh Karen guy can now go do a circle jerk together. Losers!

Why so mad, stupid? You have another three years of petulance in you, correct? You’ll still be alone and obsessed with Esperion, Dumbass Scoutmaster Karen.

 

[anonymous]

Why so mad, stupid? You have another three years of petulance in you, correct? You’ll still be alone and obsessed with Esperion, Dumbass Scoutmaster Karen.

Haha Love This!!

 

[anonymous]

I was very surprised the data wasn't better. This won't move the needle in managed care. PCSK9 is still the leader and of course generic statins.

 

[anonymous]

I was very surprised the data wasn't better. This won't move the needle in managed care. PCSK9 is still the leader and of course generic statins.

We will move needle. Also why does most of the medical community at the ACC who discuss the trial think otherwise?

 

[anonymous]

I was very surprised the data wasn't better. This won't move the needle in managed care. PCSK9 is still the leader and of course generic statins.

Landmark CLEAR Outcomes Study Demonstrates NEXLETOL® (bempedoic acid) Tablet is the Only LDL-C Lowering Therapy Since Statins to Reduce Hard Ischemic Events in a Broad Population of Both Primary Prevention and Secondary Prevention Patients

 

[anonymous]

The sentiment in medical community based on the latest news articles is neutral. This was really very overblown on how great the results were. No difference in death to placebo isn't great. Minimal reductions in LDL in comparison to statins. Esperion has a long way to go to turn a profit. Money has been going out the door at an alarming rate compared to money coming in.

 

[anonymous]

The sentiment in medical community based on the latest news articles is neutral. This was really very overblown on how great the results were. No difference in death to placebo isn't great. Minimal reductions in LDL in comparison to statins. Esperion has a long way to go to turn a profit. Money has been going out the door at an alarming rate compared to money coming in.

I Guess we have a Medical Doctor and Investment Analyst posting on this site …. No! On the contrary most physicians are quite happy with the results. Go back in your cave!

 

[anonymous]

The sentiment in medical community based on the latest news articles is neutral. This was really very overblown on how great the results were. No difference in death to placebo isn't great. Minimal reductions in LDL in comparison to statins. Esperion has a long way to go to turn a profit. Money has been going out the door at an alarming rate compared to money coming in.

What news articles are you referring too? Quite the contrary. Also, the clown writing this must be a Medical Doctor and Investment Analyst all in one. Very Impressive Sir. Go back to your cave?

 

[anonymous]

Stock down 30% in pre-market. Investors not impressed with 13%. Benchmark is 15-20% for Wall St to be impressed. Stock will be dumped hard today. You knew this was coming! It's going to be a long day.

 

[anonymous]

This is a disaster!. Down 20% and investors bailing fast. Over 10 million shares dumped this morning. Where's the Esperion big talkers today?. I for one am giddy with joy. Three years ago we said" what goes around comes around" and it has like a giant toilet flush. THANKS TO ALL WHO KEPT THE HEAT ON ESPERION ON THIS BOARD. WELL DONE. THE DATA DIDNT COME OUT THAT GREAT. THE ESPERION SUPER HEROS LIKE GIDDY UPGUY, UPTICK GUY, AND WHO COULD FORGET CB. AND GOOD OLE TIM M. ITS BEEN A PLEASURE CMUNICATING WITH ALL YOU ESPERION LACKEYS. MY WORK IS COMPLETE. GOOD LUCK IN UNEMPLOYMENT LINE AND GETTING LAUGHED AT MY DOCTORS. SO MUCH FOR THE SCIENTIFIC PROCESS. LOLOLO

 

[anonymous]

This is a disaster!. Down 20% and investors bailing fast. Over 10 million shares dumped this morning. Where's the Esperion big talkers today?. I for one am giddy with joy. Three years ago we said" what goes around comes around" and it has like a giant toilet flush. THANKS TO ALL WHO KEPT THE HEAT ON ESPERION ON THIS BOARD. WELL DONE. THE DATA DIDNT COME OUT THAT GREAT. THE ESPERION SUPER HEROS LIKE GIDDY UPGUY, 'Based upon the strength of the data and the clinical significance they represent, Esperion will be filing with the FDA and EMA by June 2023 and anticipate receipt of expanded CV risk reduction labels in 1H 2024 that will more than double the addressable treatment population for NEXLETOL and NEXLIZET', UPTICK GUY, AND WHO COULD FORGET CB. AND GOOD OLE TIM M. ITS BEEN A PLEASURE CMUNICATING WITH ALL YOU ESPERION LACKEYS. MY WORK IS COMPLETE. GOOD LUCK IN UNEMPLOYMENT LINE AND GETTING LAUGHED AT MY DOCTORS. SO MUCH FOR THE SCIENTIFIC PROCESS. LOLOLO

Well done Karens. It was your strength and fortitude that ruined Esperion. Who could have known that your obsession and flippant shenanigans would ruin a clinical trial and a company. Be proud, book many lunches, and deliver those coffees with a smile. When you're alone tonight and typing on the Esperion board, know that you are The Phoenix! You are Xena!

 

[anonymous]

Only a scumbag would defend Esperion. You lost!! It's that simple. All your stupid karen comments only made you look stupid. Thankfully this board kept the medical and financial investors informed on what type of a company Eaperion is. Nothing changes the weak data!!

 

[anonymous]

Only a scumbag would defend Esperion. You lost!! It's that simple. All your stupid karen comments only made you look stupid. Thankfully this board kept the medical and financial investors informed on what type of a company Eaperion is. Nothing changes the weak data!!

You are The Phoenix, Karen. You are Xena.